Molnupiravir 200mg Capsules

Molnupiravir 200mg is an oral antiviral used for selected adults with early COVID-19 who are at risk of progression and for whom suitable alternatives are unavailable or inappropriate.
Swallow the capsules whole with or without food, starting within five days of COVID-19 symptom onset. The adult treatment course lasts five days, with doses about 12 hours apart. It is not used as ongoing prevention after exposure.
Molnupiravir is converted to a nucleoside analogue that introduces copying errors into viral RNA, impairing replication of SARS-CoV-2.
Diarrhoea, nausea and dizziness can occur. Allergic reactions are possible.
It is not used during pregnancy or in children because of reproductive and developing-tissue concerns. Contraception counselling is relevant to the treatment course.
Can reduce progression risk when used early in an eligible patient; it is not a preventive medicine after exposure.
It acts on viral replication, which is most relevant during the early phase of illness.
No. Its treatment role is a short course for early acute infection in selected adults.
It is avoided because its mechanism creates concern about harm to the developing fetus.
No. Worsening breathing or low oxygen requires urgent clinical assessment.
SARS-CoV-2: the virus causing COVID-19. Viral RNA: the virus's genetic material. Nucleoside analogue: a compound resembling an RNA building block.; AR: Molnupiravir 200mg كبسولات; FR: Molnupiravir 200mg gélules; PT: Molnupiravir 200mg cápsulas; ES: Molnupiravir 200mg cápsulas; RU: Molnupiravir 200mg капсулы; ID: Molnupiravir 200mg kapsul; VI: Molnupiravir 200mg viên nang; MS: Molnupiravir 200mg kapsul; TL: Molnupiravir 200mg mga kapsula; ZH-SG: Molnupiravir 200mg 胶囊
International B2B Enquiry
Send a structured B2B enquiry for Molnupiravir 200mg Capsules under Antiviral. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Molnupiravir 200mg Capsules